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Abstract
Multiple positions within the SWI/SNF chromatin remodeling complex can be filled by mutu-
ally exclusive subunits. Inclusion or exclusion of these proteins defines many unique forms
of SWI/SNF and has profound functional consequences. Often this complex is studied as a
single entity within a particular cell type and we understand little about the functional rela-
tionship between these biochemically distinct forms of the remodeling complex. Here we
examine the functional relationships among three complex-specific ARID (AT-Rich Interact-
ing Domain) subunits using genome-wide chromatin immunoprecipitation, transcriptome
analysis, and transcription factor binding maps. We find widespread overlap in transcrip-
tional regulation and the genomic binding of distinct SWI/SNF complexes. ARID1B and
ARID2 participate in wide-spread cooperation to repress hundreds of genes. Additionally,
we find numerous examples of competition between ARID1A and another ARID, and vali-
date that gene expression changes following loss of one ARID are dependent on the func-
tion of an alternative ARID. These distinct regulatory modalities are correlated with
differential occupancy by transcription factors. Together, these data suggest that distinct
SWI/SNF complexes dictate gene-specific transcription through functional interactions
between the different forms of the SWI/SNF complex and associated co-factors. Most
genes regulated by SWI/SNF are controlled by multiple biochemically distinct forms of the
complex, and the overall expression of a gene is the product of the interaction between
these different SWI/SNF complexes. The three mutually exclusive ARID family members
are among the most frequently mutated chromatin regulators in cancer, and understanding
the functional interactions and their role in transcriptional regulation provides an important
foundation to understand their role in cancer.
Author Summary
The SWI/SNF chromatin remodeling complex is made of multiple subunits, and the inclu-
sion of different mutually exclusive subunits allows potentially many biochemically
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distinct forms of SWI/SNF. Members of this complex are among the most frequently
mutated genes in cancer. Here, we present the first genome-wide localization maps of
three mutually exclusive ARID subunits, and identify their role in regulating transcription.
The ARID subunits have largely overlapping localization, and affect transcription of many
of the same genes. Within these overlapping classes we identified extensive cooperation
between ARID1B and ARID2 in the repression of hundreds of genes, as well as competi-
tive interactions between ARID1A and the other ARIDs. These distinct regulatory modali-
ties were characterized by co-localization with specific transcription factors. Together
these data provide insight into the functional relationships between multiple distinct SWI/
SNF complexes. SWI/SNF controls gene expression at thousands of genes and in most of
these cases multiple distinct forms of the complex interact to specify the gene’s transcrip-
tion status in a particular cell. Understanding the role of each distinct form of SWI/SNF
within a cell is a critical first step towards untangling the effects of SWI/SNF subunit loss
in cancer.
Introduction
The SWI/SNF (SWItch/Sucrose Non-Fermentable) family of chromatin remodeling proteins
plays a critical role in developmental processes [1]. In mice and humans this complex is com-
posed of 12–15 subunits and certain positions within the complex can be filled by distinct
mutually exclusive proteins [2, 3]. The inclusion of different subunits gives rise to a function-
ally diverse set of complexes, capable of driving a cell into a specific lineage or critical for main-
taining pluripotency [4–6]. There are a large number of possible forms of the SWI/SNF
complex based on the inclusion of such mutually exclusive subunits, and despite the pivotal
role for many of these in development and disease the functional relationships between mutu-
ally exclusive subunits remains under-explored.
The ARID (AT-Rich Interacting Domain) domain containing proteins of the SWI/SNF
complex are examples of three mutually exclusive subunits, and their inclusion distinguishes
three biochemically distinct forms of SWI/SNF. ARID1A and ARID1B are found in the
BAF-A and BAF-B (Brahma Associated Factor) complex respectively, while ARID2 is found
in the PBAF (Polybromo BAF) complex. The functional interactions between distinct forms
of this heterogeneous remodeling complex have not been studied genome-wide. All three
ARID genes are mutated in a wide variety of tumors [7–15]. Of particular interest to our
study, all three are recurrently mutated in hepatocellular carcinoma and mutations are mutu-
ally exclusive suggesting they function through related mechanisms [10–12]. A current focus
of therapeutically targeting SWI/SNF mutant tumors is based on findings of synthetic lethal-
ity between subunits, yet we currently understand little about how these subunits function-
ally interact [16, 17].
In this paper we examine two questions related to the functional overlap of distinct forms of
the SWI/SNF remodeling complex. First, do different SWI/SNF complexes extensively cooper-
ate or compete to regulate transcription? Second, do distinct forms of the SWI/SNF complex
interact with unique or common cis-regulatory modules to mediate their role in transcription?
To address these questions we performed ChIP-seq and RNA-seq in HepG2 cells, a human
liver cancer cell line for which extensive transcription factor binding data are available from
the ENCODE project [18].
Modes of SWI/SNF-Mediated Transcriptional Control
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We present evidence that ARID1A, ARID1B, and ARID2 have a highly overlapping role in
transcriptional regulation in HepG2 cells. Additionally, we provide the first genome-wide map-
ping of biochemically distinct SWI/SNF complexes and show a high degree of overlap between
binding sites for the different ARID proteins. We identify putative regulatory modules specific
for the different types of ARID mediated regulation. Using RNAi against combinations of
ARIDs we show ARID1A and ARID2 have frequent competitive interactions, while ARID1B
and ARID2 are both required for repression and are not redundant. Our study provides insight
into how distinct forms of the SWI/SNF complex regulate transcription in an interdependent
manner and provides mechanistic insight into recent observations of synthetic lethal interac-
tions between SWI/SNF subunits [16, 17, 19].
Results
Identification of genes regulated by ARID proteins
All three ARID members of the SWI/SNF complex are expressed in the human liver cancer cell
line HepG2, and in hepatocellular carcinoma all three ARIDs are recurrently mutated in a
mutually exclusive fashion [10–12]. ARID1A is expressed at the highest level in most cell types
including HepG2, while ARID2 is expressed at a lower level (S1 Fig, ARID1A = 18.9 TPM
(transcripts per million), ARID1B = 13.4 TPM, ARID2 = 8.3 TPM in ENCODE data [18], S1
Fig) Using RNAi we depleted each of the ARID subunits and asked whether they controlled
unique transcriptional programs. We were able to reduce the expression levels of all three
ARID genes to 25–50% of normal levels (S2A and S2B Fig). The moderate level of knockdown
achieved and the short duration of the experiment (72 hours) may allow cells to remain healthy
while still allowing the detection of gene expression changes. We identified 284, 1289, and 2682
differentially expressed genes following ARID1A, ARID1B, and ARID2 knockdown at a FDR
of 0.1 for ARID1A, and 0.05 for ARID1B and ARID2. We validated expression changes using a
second set of siRNAs for selected genes using qPCR (S3A–S3C Fig). ARID1A and ARID2 loss
caused similar proportions of genes to be up-regulated compared to down-regulated (116 up-
regulated, 168 down-regulated ARID1A; 1459 up-regulated, 1223 down-regulated ARID2).
However, ARID1B depletion led to increased expression in more than twice as many genes as
decreased expression (865 up-regulated, 424 down-downregulated), suggesting ARID1B had a
more prominent role in repression in HepG2 cells.
Given previous examples in the literature of competitive interactions between ARID family
members in different developmental contexts [4, 5, 20, 21], we hypothesized that ARID pro-
teins would regulate overlapping gene sets. We calculated the fraction of genes altered by one,
two, or three ARID family members. This revealed that 41% (ARID1A), 54%(ARID1B), and
27% (ARID2) of genes were affected by the loss of more than one ARID (Fig 1A), an overlap
that is significant for each of the three ARIDs (ARID1A 2.6 × 10−12, ARID1B<2.2 × 10−16,
ARID2<2.2 × 10−16; hypergeometric test). In the remainder of the manuscript we refer to
genes transcriptionally regulated by a single ARID as ‘alone’ and those regulated by more than
one ARIDs as ‘jointly’ (S10 Table). We performed pathway analysis on the alone and jointly
regulated gene sets for each ARID (S7, S8 and S9 Tables). ARID1A alone genes were enriched
for numerous gene sets involved with liver cancer and liver development. While ARID1B and
ARID2 joint categories both were enriched for HDAC target genes and SMAD signaling.
In total, loss of an ARID protein affected the expression of 3453 unique genes of the total
17157 genes expressed at a level detected in our data set (20.1%). Of these 3453 genes 747 were
affected by multiple ARIDs (21.6%). Together, these data suggest an extensive role for func-
tional interaction among biochemically discrete forms of SWI/SNF.
Modes of SWI/SNF-Mediated Transcriptional Control
PLOS Genetics | DOI:10.1371/journal.pgen.1005748 December 30, 2015 3 / 26
ARID proteins regulate gene expression in both a concordant and
discordant manner
We next compared the direction of gene expression changes of genes regulated alone with
genes regulated jointly (Fig 1B). While ARID1A regulated roughly an equal number of genes
positively and negatively in the alone and joint categories, ARID1B and ARID2 loss caused dis-
tinct effects at genes regulated by multiple ARIDs. When ARID2 is the only Arid affecting
expression of a gene, it is equally likely to repress a gene as it is to activate a gene. However,
when ARID2 and another ARID regulate the same gene, ARID2 is twice as likely to repress the
target gene (Chi-squared p-value 1.64 × 10−37). While ARID1B primarily represses genes, it
also is significantly more likely to repress transcription when functioning with another Arid
(Fig 1B, Chi-squared p-value 1.9 × 10−7).
If ARID subunits are mainly functioning in opposition in HepG2 cells we would expect
them to have discordant effects on gene expression. We compared changes in expression for
pairs of ARID proteins at jointly regulated genes. Those genes where both ARIDs caused an
Fig 1. Analysis of ARIDmediated transcriptional regulation. A. Number of genes altered by loss of an ARID that are affected by one, two, or three ARIDs.
B. Direction (Activated or Repressed) of gene expression changes in alone compared to jointly regulated genes (ARID1A—Not Significant, ARID1B—p-
value = 1.9 × 10−7, ARID2—p-value = 1.64 × 10−37, Chi-squared test). C. Pair-wise comparison of Log2 Fold Changes following knockdown of each ARID
shows the numbers of genes regulated in the same direction (concordant—blue) compared to regulated in an opposing manner (discordant—pink). Positive
values for log2 fold change indicate repressive action, while negative log2 fold change values indicate activation. ARID1A—ARID1B r2 = 0.185, p-
value = 0.001; ARID1A-ARID2 r2 = 0.03, p-value = 0.054; ARID1B-ARID2 r2 = 0.85, p-value <2.2 × 10−16)
doi:10.1371/journal.pgen.1005748.g001
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expression change in the same direction are said to be concordant, while those regulating
expression in opposite directions are called discordant. From this analysis we cannot conclude
the complexes directly compete or cooperate, but instead use these terms in relation to the
functional consequence of the dual regulation by a pair of ARID proteins. When ARID1B or
ARID2 were regulating genes in conjunction with ARID1A there we observed both concordant
and discordant changes (ARID1A-ARID1B r2 = 0.185, ARID1A-ARID2 r2 0.03, Fig 1C).
However, when ARID1B and ARID2 regulated the same gene there was an extreme degree
of concordance (Fig 1C, r2 = 0.85, p-value <2.2 × 10−16). The majority of these interactions
consisted of a requirement for both ARID1B and ARID2 to repress gene expression. Together
these results suggest that ARID1B and ARID2 regulate a highly similar transcriptional
network.
ARIDs bind at active genomic regions
Given the high degree of overlap in the regulation of gene expression by each ARID, we
hypothesized there would be extensive overlap in the binding sites for the ARID subunits.
Widespread genomic co-localization of distinct families of chromatin remodelers has been
observed in mouse mammary epithelial cells [22], suggesting co-occupancy of chromatin
remodeling complexes may be a general feature of transcriptional control mediated by chroma-
tin remodeling complexes. We used ChIP-seq to identify the binding sites of ARID1A,
ARID1B, and ARID2. We also mapped the genomic location of BAF47 (SNF5/INI1/
SMARCB1), a core SWI/SNF member previously mapped by ChIP-seq in HeLa cells [23]. We
identified 12852 ARID1A, 8728 ARID1B, 12995 ARID2, and 20718 BAF47 peaks (S1, S2, S3
and S4 Tables). Each ARID subunit individually had high overlap with BAF47 bound regions
(63–72%, S4A–S4C Fig). The union of all ARID bound regions overlapped approximately 73%
of BAF47 bound regions in our dataset (S4D Fig). Additionally, we compared BAF47 bound
regions to BAF47 binding sites identified by Euskirchen et al. and found 80% of the peaks iden-
tified in that dataset were also found in our dataset (S4E Fig). Together this suggests we identi-
fied a large number of the true binding sites for these factors in HepG2 cells.
We then compared ARID binding at all transcription units in HepG2 cells (Fig 2A). All
three ARIDs bound near the transcription start site (TSS) of most expressed transcripts. Very
little ARID binding was localized to non-expressed transcripts suggesting ARID binding corre-
lates with active transcription (Fig 2A and 2B, Wilcoxon test p-value<2.2 × 10−16).
Using ENCODE data in HepG2 cells, we performed a similar analysis using all enhancers
identified in HepG2 cells [18]. We defined enhancers as overlapping peaks of p300 and
H3K4me1 that were greater than 2kb from the nearest TSS [18, 24]. We further subdivided
these regions based on the presence (active) or absence (poised) of H3K27ac. ARID binding
was evident at nearly all enhancers, with stronger signal associated with more H3K27ac, sug-
gesting ARID binding correlated with potential enhancer activity (Fig 2C and 2D, Wilcoxon
test p-value<2.2 × 10−16)).
Finally, we analyzed the distribution of peak locations to determine if biochemically distinct
forms of SWI/SNF localized to common types of genomic features. ARID1A and ARID2 were
found at similar annotations in the genome. These peaks were more skewed towards promoters
and gene bodies (exons), while ARID1B bound to more distal and intronic features. Over 70%
of ARID1A peaks were in promoters of genes (TSS +/- 2kb), while ARID2 peaks were slightly
less localized to the promoter (60%), and ARID1B peaks were found in promoters only 25% of
the time (Fig 2E). This distribution suggests ARID1B may be more commonly found at
enhancers, which is reflected in the chromatin modifications present at the ARID bound
regions. ARID1A and ARID2 peaks had more H3K4me3, consistent with the proximity of
Modes of SWI/SNF-Mediated Transcriptional Control
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these peaks to promoters, while ARID1B peaks were marked by more H3K4me1 consistent
with ARID1B localizing to enhancers (S5 Fig). The genomic distribution of SNF5 was interme-
diated to that of the ARIDs (Fig 2E).
ARID proteins localize primarily to common genomic regions
Given the high level of signal for each ARID at promoters and enhancers it is apparent that
many of the ARID binding sites in the genome are shared by more than one ARID. We found
approximately half of the sites for a particular ARID were bound by multiple ARIDs
(ARID1A = 54%, ARID1B = 42%, ARID2 = 50% Fig 3A). However, a relatively small set of
1632 of 25226 total peaks were bound by all three ARIDs (6.5%), despite the apparently high
Fig 2. Identification of ARID bound regions A. ChIP-seq signal aligned to all transcripts (Gencode annotations V16). Rows in top panel correspond to
17158 expressed transcripts from RNA-seq data, ordered by relative expression level. Bottom panel is all remaining non-expressed/lowly expressed
transcripts unordered. B. Signal of each ARID at the different classes of transcription start sites (quantification of panel A). C. ChIP-seq signal aligned to all
enhancers defined using ENCODE data for p300 and H3K4me1. Enhancers are greater than 2kb from the nearest TSS and active enhancers (top panels—
19707 enhancers) are distinguished from poised enhancers (bottom panel—10622 enhancers) by presence of H3K27ac. D. Signal of each ARID at active
compared to poised enhancers (quantification of panel C). E. Location of ARID bound regions relative to genomic features.
doi:10.1371/journal.pgen.1005748.g002
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level of signal associated with all promoters and enhancers (Fig 2A and 2B). One possibility is
that lower than expected overlap between peaks is a reflection peak of calls that are overly con-
servative. To address this we split each set of ARID bound regions into ‘single’ and ‘multiple’
categories and calculated ChIP signal for each ARID at these peaks. This demonstrated that the
‘single’ designation is not simply a reflection of peak calling (Fig 3B, S6 Fig). For example, there
was less ARID1B and ARID2 binding at ARID1A single peaks compared to ARID1A multiple
peaks (S6 Fig). However, there are examples of mis-categorized loci in this analysis, likely due
to the technical challenge of defining the true set of ARID bound regions. We therefore con-
sider the ‘single’ category to be an overestimate of the true number of peaks bound only by a
single ARID.
Using these categorizations we evaluated whether ‘single’ compared to ‘multiple’ bound
ARID peaks localized to different types of genomic elements. ARID1A single bound regions
were distributed similar to ARID1A multiple bound regions within the genome. However, for
ARID1B and ARID2, binding sites in the promoters or exons of genes were more often bound
by multiple ARIDS while sites located in introns or in intergenic regions were only bound by
multiple ARIDS approximately 40% of the time (Fig 3C). Common and more highly occupied
sites tended to be associated with promoters (Fig 3C and 3D). For example, at the KLF6 locus a
strong signal for all three ARIDs is localized in the vicinity of the KLF6 transcription start site
(TSS), while an upstream regulatory element is more variably occupied (Fig 3D). Similarly at
theMYC locus, all three ARIDs bind near the TSS, with more variable binding at presumed
enhancers distally located. For the remainder of the analysis of ARID bound regions, we
Fig 3. Overlap of ARID binding. A. Venn-diagram depicting overlap among peaks for each of three ARID proteins. B. Comparison of signal at ARID1A
alone, ARID1B alone, ARID2 alone, and Multiple bound ARID regions. C. Genomic distribution for ARID peaks, categorized by whether the peak was bound
by a single ARID or multiple ARID subunits. D. Example of ARID1A, ARID1B, and ARID2 binding at the KLF6 (top) andMYC (bottom) loci. Colored bars
denote called peaks for each ARID. All scales are equal, and are normalized to reads per 30bp per 10 million mapped reads. E. Co-immunoprecipitations
with each ARID subunit followed by western blotting for each ARID subunit as well as BAF180 (PBAF subunit), and BRG1.
doi:10.1371/journal.pgen.1005748.g003
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separated peaks into those that were bound by ARID1A, ARID1B, or ARID2 alone and a set of
‘multiple’ peaks derived from regions bound by more than one ARID. Despite the frequent co-
occurence of ARID binding, we did not detect direct physical association between the ARIDs
under low stringency co-immunoprecipitations (Fig 3E). However, we detected PBRM1 (also
known as BAF180) ARID1A immunoprecipitations, consistent with previous reports [25].
ARID subunits localize with distinct chromatin regulators and
transcription factors
Large groups of chromatin regulating proteins co-localize to common genomic regions [26].
Given that multiple bound sites were most commonly associated with promoters, while single
bound loci were more variable in genomic location, we hypothesized that distinct forms of
SWI/SNF would co-localize with transcription factors or chromatin regulators based on the
type of ARID interaction. For example, ARID1A only bound regions might recruit different
chromatin regulators than ARID1B only bound regions. To identify distinct co-regulatory
modules for each type of ARID bound region we used ENCODE ChIP-seq data from HepG2
cells [18] (77 data sets, see S5 Table for details). Using these data sets we evaluated the enrich-
ment for each factor and the correlation between pairs of factors at each of the four peak classes
(ARID1A only, ARID1B only, ARID2 only, and multiple bound sites).
We clustered the ENCODE ChIP-seq data based on Spearman correlation coefficient and
removed any transcription factors or histone modifications that were not enriched above a
minimum level (S7A–S7D Fig). Using the clusters assigned to each factor we compared how
similar any two clusters were using the number of shared factors as a measure of similarity
between clusters (Fig 4A). One cluster consisted mainly of histone modifications, and these
modifications were enriched highly at each of the four peak classes. Both active (H3K4me2 and
H3K27ac) and inactive (H3K27me3, EZH2) modifications were shared between ARID2 and
Multiple bound clusters, while these modifications were split into two separate clusters for
ARID1A (Clusters 5 and 7). The same histone modifications were also enriched at ARID1B
alone bound sites, but were located in a cluster containing many other transcriptional regula-
tors. The largest group of clusters (Group A Fig 4A), contained both positive general transcrip-
tion activators (MAX, TBP) as well as negative regulators (COREST, SIN3A). A second cluster
of transcriptional regulators (Group B Fig 4B) is seen for all four peak classes and contains tis-
sue-specific transcription factors such as HNF4-α, HNF4γ, and FOXA1. Within a set of peaks
(ARID1A, ARID1B, ARID2, Multi) enrichment of these transcription factors was relatively
consistent. We clustered peaks based on enrichment scores for several defining members of the
above clusters and most peaks fell within one large cluster for each group (Fig 4B).
We also identified one cluster (ARID1B Cluster 8, Fig 4B) that shared no connections with
enriched clusters at the other peaks. This cluster contained four genes (NFIC, TEAD4, MYBL2,
MBD4, Fig 4B, S8 Fig). NFIC (Nuclear Factor I/C) is involved in transcriptional activation and
replication. TEAD4 (TEA Domain Family Member 4) is a member of the transcriptional
enhancer factor (TEF) family of proteins. It is not normally expressed in the liver, but it is up-
regulated in cancer. MYBL2 (v-myb avian myeloblastosis viral oncogene homolog-like 2) is a
transcription factor involved in cell cycle progression as a member of the DREAM (dimeriza-
tion partner, RB-like, E2F and multi-vulval class B) complex where it represses cell-cycle
dependent genes [27]. MBD4 (Methyl-CpG Binding domain protein 4) is a protein that inter-
acts with DNMT1 and other histone modifiers and is important for repression. All four factors
were more enriched at distal and intronic ARID1B bound loci than at promoter proximal bind-
ing sites, suggesting they may be involved in repression at ARID1B-regulated enhancers (S8
Modes of SWI/SNF-Mediated Transcriptional Control
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Fig). These subunits have not previously been tied together directly, but their co-occupancy at
ARID1B alone sites suggests a potentially novel repressive complex with ARID1B.
We explored the enrichment of some factors identified in Fig 4 in more detail by comparing
the binding levels of these factors at the four classes of ARID bound peaks. In most cases, peaks
defined by multiple ARID binding recruited higher levels of a transcription factor or histone
modification, suggesting some contribution from more than one ARID in the binding of these
factors or presence of these modifications (Fig 4C). In agreement with our earlier data showing
Fig 4. Identifcation of transcription factor clusters at ARID bound regions. A. Network diagram of similarity between cluster assignments for each ARID.
Edge weight signifies the number of transcription factors or histone modifiers common to both nodes, and the color of the node signifies which ARID peak set
the cluster refers to (see Materials and methods for details). Placement of nodes within the network is done using the qgraph R package and the ‘spring’
layout. B. Enrichment of transcription factors at different peak sets. Colored bar along top indicate KMeans cluster assignment of the peaks (k = 3). C.
Metagene plots centered at the ARID bound peak center +/- 2.5kb for each of the ChIP-seq signals more common at ARID1A bound regions, and D. ARID1B
bound regions. For all panels line represents the average signal centered on a particular class of ARID peaks, with the shading depicting the 95% confidence
interval.
doi:10.1371/journal.pgen.1005748.g004
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ARID1A and ARID2 were associated more with promoters, we see histone modification pro-
files that reflect that localization at ARID1A single and ARID2 single peaks (H3K4me3,
H3K27ac, no H3K4me1). Additionally, factors predicted to cluster together at ARID1A,
ARID2, and multiple bound sites, such as MAX and YY1, are present at higher levels at these
peaks than at ARID1B single peaks (Fig 4C). At ARID1B single bound regions, which are more
often associated with enhancers, we see high levels of H3K27ac and H3K4me1 as expected. In
agreement with the clustering analysis we also find ARID1B bound peaks are enriched for
higher levels of TEAD4, FOXA1, MYBL2, and HNF4γ compared to the ARID1A or ARID2
single bound regions (Fig 4D). Interestingly, ARID1B alone regions, but not multi regions were
enriched for FOXA1 and TEAD4, suggesting these factors bind only when ARID1A or ARID2
are not present. Together, these data suggest that although binding sites for biochemically dis-
tinct SWI/SNF primarily overlap, and they share many co-factors, functional interaction with
distinct transcriptional co-regulators can be revealed by examining regions bound only by a
single ARID.
De-repression of ARID1B/ARID2 regulated genes requires ARID1A
To determine if gene expression changes following depletion of one ARID required the activity
of another ARID we selected a set of genes that were significantly altered following loss of
more than one of the ARID proteins and were direct targets of regulation based on ChIP-seq
for multiple RNAi experiments. The most common type of functional relationship found
among the ARID subunits is a repression mediated by both ARID1B and ARID2. Of 116 genes
directly bound by both ARID1B and ARID2 and up-regulated following their depletion, 43
genes were down-regulated following ARID1A loss, although not to a statistically significant
level in the RNA-seq data. One such example is EPHA2, where both ARID1B and ARID2 loss
led to up-regulation while ARID1A loss led to down-regulation. All three ARIDs bind to sites
within the promoter and in the first intron, while ARID1A and ARID1B also localize to a
region upstream of the TSS (Fig 5A). We performed combinatorial knockdowns alongside sin-
gly depleted ARID subunits to determine if ARID1A and ARID2 were competitively interact-
ing at these regions. Additionally, we performed multiple knockdown experiments targeted at
ARID1B and ARID2 together to determine if they function synergistically.
We saw depletion of the single ARID subunits at a level consistent with the RNA-seq mea-
surements, and again did not see any depletion of the non-targeted ARIDs. Knockdown of
multiple ARID subunits in a single cell led to decrease in only the correct ARIDs (Fig 5B, S9A
Fig). Following single knockdown of ARID1A in these five genes, we noted decreases in gene
expression, and single ARID1B or ARID2 depletion caused increases in transcription levels as
expected from the RNA-seq data (Fig 5C). When ARID1A and ARID2 were simultaneously
depleted, expression at these genes was rescued to near wild type levels (EPHA2, RRAS,
S100A14), or remained down-regulated relative to a non-targeting control (SPOCK2, TNS4)
(Fig 5C). We confirmed this depedence using as second set of siRNAs (S9B and S9C Fig). This
is consistent with a competitive model for ARID1A and ARID2 regulation at these genes,
where ARID1A functions in transcriptional activation while ARID1B and ARID2 function in
transcriptional repression.
ARID1B and ARID2 functioned concordantly nearly 100% of the time (Fig 1C), and we
next looked at these concordant relationships to determine if repression by ARID1B and
ARID2 were truly cooperative, or whether there was a synergistic effect of their combined
depletion. Knockdown of ARID1B and ARID2 showed there was no additional de-repression
from their combined loss, consistent with a cooperative relationship between ARID1B and
ARID2 in the repression of these genes (Fig 5C),.
Modes of SWI/SNF-Mediated Transcriptional Control
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We then tested whether loss of ARID1A from genes regulated by both ARID1A and ARID2
led to a recruitment of ARID2 and a change in the histone modifications present at these
genes. We selected six genes that were bound by multiple ARIDs and were associated with
decreased gene expression following ARID1A loss and increased gene expression following
ARID2 loss (Fig 6A). Using two shRNAs targeting ARID1A we decreased ARID1A expression
in HepG2 cells and monitored the levels of ARID1A, ARID2, and H3K27ac levels present at
these genes (Fig 6B). We achieved moderate loss of ARID1A from these genes, and did not
detect a consistent change in ARID2 binding at these loci (Fig 6C). This may reflect the incom-
plete knockdown achieved, or may be due to the relatively broad peaks of ARID associated
with these genes. However, we did note a decrease in H3K27ac levels at multiple genes consis-
tent with the requirement of ARID1A for activation at these sites (Fig 6C).
Direct targets of ARID regulation
Next we sought to determine what fraction of genes were directly regulated by ARID binding.
To address this we first assigned each ChIP peak to the nearest gene and for each set of peaks
we determined what fraction was associated with a gene that was altered following knockdown.
This showed that 30–50% of genes were putative direct targets of the associated ARID (Fig
7A). ARID1A knockdown led to the least number of total changes in gene expression, but we
found more than half (54%) of those genes were assigned to an ARID1A bound peak (p-
value = 0.03, hypergeometric test) Genes misregulated following ARID1B loss were less com-
monly assigned as direct targets (30%, not significant), suggesting that many of the ARID1B
bound regions function somewhere other than the closest gene, and consistent with a more
enhancer-like localization for ARID1B. ARID2 also directly targeted a highly significant per-
centage of altered genes (46%, p-value = 3.4 × 10−16 hypergeometric test). A table of all
Fig 5. Multiple knockdown of ARID genes. A. The EPHA2 locus is an example of a gene regulated by multiple ARIDs. Colored bars depict locations of
called peaks. All ChIP-seq signal intensities are normalized to reads per 30bp per 10 million mapped reads and are shown on the same relative scale. B.
Single and combinatorial knockdown of ARID1A, ARID1B, and ARID2 and followed by qPCR expression measurements of the ARID genes. C. Expression
changes in a panel of genes expected to be up-regulated by the loss of either ARID1B or ARID2, and down-regulated following loss of ARID1A. Error bars
represent 95% confidence intervals and the experiment was repeated a minimum of 4 times.
doi:10.1371/journal.pgen.1005748.g005
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expressed genes with transcription changes and ARID binding status can be found in
BibliographyS16.
We next repeated the analysis of concordant and discordant gene expression changes (Fig
1C) to determine if the direct targets of ARID regulation also controlled similar transcriptional
programs. The same pattern of both concordant and discordant regulation occurred between
ARID1A and ARID1B or ARID2 (S10 Fig). Additionally, ARID1B and ARID2 direct targets
shared a highly concordant pattern of transcriptional changes, consistant with the transcrip-
tion changes observed for the whole gene set. The analysis of direct (S10 Fig) and potentially
indirect regulatory (Fig 1) provide bounds for the ARID regulated transcriptional programs.
Evaluating the ARID ChIP-seq signal shows many genes that are not associated with a peak, in
fact have moderate levels of ARID binding that may reflect direct control as well (S10 Fig).
ARID1B and ARID2 alone and multiple peaks were associated with distinct genomic
regions. We next asked if direct targets of ARID1B and ARID2 regulation were associated with
ARID peaks at distinct genomic regions, and whether this distribution was different for acti-
vated compared to repressed genes. ARID1B peaks associated with repressed genes were more
likely to be bound in an intron than were genes associated with activation following ARID1B
loss, consistent with a model where ARID1B is involved in enhancer repression (S11 Fig). In
Fig 6. Knockdown of ARID1A leads to decrease in ARID1A binding and H3K27ac. A. Six loci were selected based on the presence of both ARID1A and
ARID2 and the opposing gene expression changes associated with ARID1A and ARID2 depletion. Primer locations are noted by a black bar. B. Western blot
on ARID1A and ARID2 in HepG2 cells stably transduced with a non-silencing or two ARID1A shRNAs (TRCN0000059091: shRNA-1, TRCN0000059090:
shRNA-2). C. ChIP-qpcr analysis in cell lines from B. Error bars represent SEM of 3 independent experiments. Asterisk denotes p-value <0.05 by two-tailed T
test.
doi:10.1371/journal.pgen.1005748.g006
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contrast, there was no statistically significant difference for the ARID2 genomic localization.
These data demonstrate distinctions between ARID complexes associated with activation and
repression and suggest that subsetting the complex based on inclusion of a particular ARID
subunit is insufficient to capture all the heterogeneity of SWI/SNF transcriptional regulation.
The co-factors associated with each of the distinct ARIDs may be unique to each type of
transcriptional regulation. To address these relationships we considered two sets of directly
Fig 7. Transcription factor binding at different classes of direct ARID targets. A. Percent of differentially expressed (DE) genes associated with an
ARID. Asterisk denotes statistical significance p <0.01 by hypergeometric test. B. Median signal measured at the mid-region of the peak (3kb) comparing
ARID1A and ARID2 peaks associated with competitive or cooperative interactions. There were 63, 37, 58, 23 peaks associated with ARID1A cooperativity,
ARID1A competition, ARID2 cooperativity, ARID2 competition respectively. C. Median signal over mid-region of peak (3kb) comparing peaks associated with
activated or repressed peaks. There were 88, 287, 119, 489 peaks associated with ARID1B activation, ARID1B repression, ARID2 activation, and ARID2
repression respectively. In both B and C differences for all transcription factors and histones were compared byWilcoxon Rank Sum Test for each set of
ARID peaks comparing activated and repressed or competitive and cooperative. We adjusted p-values using Benjamini-Hochberg correction for multiple
testing, asterisk indicates p-value <0.05. D. Model for combinatorial control of transcription by distinct ARID complexes.
doi:10.1371/journal.pgen.1005748.g007
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regulated genes, those regulated by ARID1B and ARID2 and those regulated by ARID1A and
ARID2. We split each set based on the relationship between the ARIDs in the RNA-seq data.
For ARID1B and ARID2, we compared peaks associated with activation to those associated
with repression, and for ARID1A and ARID2 we compared peaks associated with cooperation
to those associated with competition. Identification of enriched transcription factors specifi-
cally associated with one of these groups relative to the others would provide evidence of het-
erogeneity within SWI/SNF complexes defined by inclusion of a particular ARID subunit.
Most factors bound at sites associated with ARID1A and ARID2 regulated genes were
found equally at competitive and cooperative genes (S12 Fig). This is likely in part due to the
low number of peaks that fit these criteria. However, we identified some differences between
groups that may reflect the regulatory landscape of competitive interactions. Factors involved
in transcriptional activation, such as FOSL2 (FOS-Like Antigen 2) and MAZ (MYC-Associated
Zinc Finger Protein) were more enriched at sites associated with competitive interaction
between ARID1A and ARID2 (Fig 7B). The higher level of these factors at the ARID1A bound
regions support a role for ARID1A in transcriptional activation as observed in Fig 5C. We also
noted an enrichment for the negative transcriptional regulator COREST (REST corepressor 1)
at competitively regulated ARID1A and ARID2 peaks. Further, we noted enrichment at both
cooperative and competitive bound peaks for other transcriptional repressors such as EZH2,
HDAC2, and SIN3A (S12 Fig). The enrichment of these repressive factors is consistent with a
role for ARID2 in repression of many co-regulated target genes (Fig 1B) and a model in which
de-repression following ARID2 loss is dependent on ARID1A (Fig 7D).
We identified several factors that were specific for either active or repressive associated
peaks (S13 Fig). For example, at genes associated with peaks of ARID1B and ARID2, that were
activated by both ARID1B and ARID2, we found enrichment for BRCA1 and MAX (Fig 7C).
Both have previously been found to associate with the SWI/SNF complex either directly or
through genetic interaction [19, 28, 29], but have not been linked to a specific form of the SWI/
SNF complex. Additionally, we found recruitment of TEAD4 associated with repression medi-
ated by ARID1B (Fig 7C). There is a difference in TEAD4 for and TCF7L2 enrichment between
ARID2 activated and repressed sites, but notably, the levels of binding associated with these
sites are low, consistent with these factors being recruited specifically to ARID1B bound sites
associated with transcriptional repression. These findings are consistent with a model in which
ARID1B and ARID2 function coordinately to repress transcription, but may do so through
binding distinct sites and using distinct co-factors. In cases where ARID1B and ARID2 coordi-
nately activate transcription, they may function together through common binding factors
(Fig 7D).
Discussion
Distinct SWI/SNF complexes have numerous genomic and functional
interactions
Chromatin regulating proteins bind throughout the genome and play a critical role in tran-
scriptional regulation. Studies have shown genomic co-localization for many chromatin regula-
tors [26] as well as for different chromatin remodeling families [22]. Loss of appropriate
chromatin remodeling can have genome-wide effects on transcription and chromatin structure
[30]. Using three mutually exclusive subunits of the SWI/SNF complex we delineate several
classes of functional relationships between biochemically distinct forms of this complex.
Using RNA-seq and ChIP-seq we classified transcriptional regulation based on the whether
a gene was regulated by a single ARID containing complex, or by multiple ARID complexes.
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Additionally, we classified shared regulatory function based on whether two ARID proteins act
concordantly or discordantly to regulate transcription. Using our ChIP-seq data combined
with the rich dataset provided by the ENCODE project [18] we were able to identify differences
in each of these classes.
ARID1B and ARID2 coordinately regulated transcription of a large set of genes. The major-
ity of this overlap was seen in genes cooperatively repressed by ARID1B and ARID2. While
SWI/SNF has been shown to function in repression [31–34], no study has previously shown
repression mediated through a cooperative function of two distinct SWI/SNF complexes.
Depletion of both ARID1B and ARID2 at the same time did not further enhance this de-
repression suggesting they function in the same pathway. Many of these targets were also
directly bound by ARID1B and ARID2. However, not all of these sites were occupied by both
ARID1B and ARID2, which given their cooperative role in transcriptional regulation is surpris-
ing. One possibility is the cooperativity reflects a repressive role for each individually at distinct
regulatory sites of a gene, and loss of a single ARID is enough to de-repress the locus. Consis-
tent with this ARID1B peaks directly associated with repression tended to be more localized to
introns, and non-overlapping with other ARIDs.
Understanding how ARID1B and ARID2 mediate these cooperative activities is an impor-
tant ongoing question. Our study suggests one possible mechanism involves the co-factors
recruited to each class of sites. When ARID1B and ARID2 are activating gene expression, these
sites appear more commonly located near the transcription start site. Additionally, these sites
are occupied by transcriptional activators such as BRCA1 and MAX, both of which have previ-
ously been linked to SWI/SNF function [19, 35], but these interactions have not been linked to
a specific form of the SWI/SNF complex (Fig 7D). When ARID1B is associated with repression,
it either recruits or is recruited by factors such as TEAD4 or TCF7L2 (Fig 7D). We cannot at
this point determine whether the ARIDs drive recruitment of other factors to these sites or vice
versa, although there is precedent for unique co-factors recruiting SWI/SNF to drive tissue spe-
cific gene activation [36]. Together this suggests that not only do ARID1B and ARID2 distin-
guish biochemically distinct forms of SWI/SNF (BAF-B vs PBAF complex), but the
combinatorial assembly of SWI/SNF with other transcription factors and co-regulators defines
functionally distinct complexes.
We identified many examples of competitive interactions amongst the ARID subunits, and
validated the mechanistic importance of this competition (Fig 5C). This supports several stud-
ies that have shown transcriptional changes at single genes following loss of a SWI/SNF mem-
ber depend on the remaining complex. The broad overlap we observe in transcriptional
regulation (Fig 1A) suggests direct competition is a general mechanism of SWI/SNF regulatory
control [4, 5, 20, 37]. Using genes that were altered by both ARID1A and ARID2 depletion, as
well as were bound by both ARIDs we identified co-factors mapped by the ENCODE project
that were specifically enriched near sites associated with competitive interactions compared to
cooperatively regulated genes. We found both transcriptional activators, such as the MYC
interacting protein MAZ, as well as a negative regulators, such as COREST at competitively
regulating genes. Given the dependence on ARID1A for expression following ARID2 loss, this
suggests a mechanism where ARID1A recruits or stabilizes transcriptional activators to the
promoter, while ARID2 is necessary for repression (Fig 7D). Our study did not reveal a direct
replacement of ARID1A by ARID2 following knockdown. However, this may be related to the
difficulty of ChIP for this factors and the broad enrichment peaks. Future work evaluating
swapping of biochemically distinct SWI/SNF complexes genome wide using models which
allow a complete loss of one complex will shed light on the mechanisms of the different types
of regulation we observe.
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Combinatorial regulation by SWI/SNF in cancer
Evidence of a central role for SWI/SNF in oncogenesis comes from the increasing variety of
tumors in which the complex is recurrently mutated [14, 38–40]. In some cases loss of specific
types of the SWI/SNF complex can be important in the conjunction with misregulation of cer-
tain signaling pathways. For example, a synergistic oncogenic event triggered by ARID1A loss
and PIK3CA activation leads to ovarian clear cell carcinoma in an animal model [41]. Addi-
tionally, in the background of NOTCH-dependent T-ALL, PBAF complexes are required for
continued tumor proliferation [42]. Both cases demonstrate an interaction between signaling
pathways and chromatin regulation, however in one example, the loss of a SWI/SNF complex
is necessary for tumor formation, while in the second a specific SWI/SNF complex is required
for continued tumor growth. Finally, some forms of the SWI/SNF complex have been shown to
have direct oncogenic effects through their role in transcriptional regulation. In synovial sar-
coma a fusion of a SWI/SNF subunit (SS18) to SSX leads to the eviction of SNF5 from the com-
plex and mis-localization of SWI/SNF ultimately resulting in inappropriate activation of a
proliferative transcriptional program [43]. These recent mechanistic insights into SWI/SNF
mediated mis-regulation in cancer highlight the importance of understanding the functional
relationships between the many possible forms of this complex.
The idea of therapeutically targeting SWI/SNF, either in the context of other SWI/SNF
mutations, or in tumors with specific genetic lesions, is beginning to gain traction [17, 19].
When considering how these synthetic lethalities manifest, it is important to consider how the
remaining subunits of SWI/SNF contribute to the overall transcriptional program of a cell. We
identify widespread functional interaction between distinct forms of the SWI/SNF complex
that in many cases depends on the remaining SWI/SNF in the cell. Given the broad role of
SWI/SNF in gene regulation (21% of genes expressed in HepG2 cells), it is likely that these
types of interactions are common to other cell types, and the discovery of more interactions
will shed light on the functional relationships within the SWI/SNF complex. The existence of
both competitive and cooperative interactions between distinct SWI/SNF complexes provides
mechanistic clues into synthetic lethality involving SWI/SNF and is an intriguing opportunity
to identify new therapeutic targets specific to mis-regulation of the complex [17, 19].
Materials and Methods
Cell culture
HepG2 cells (UNC Tissue Culture Facility) were grown in DMEM (Gibco, Life Technologies)
supplemented with 10% Fetal Calf Serum and penicillin/streptomycin (100units/mL, Life
Technologies).
Antibodies
Arid1a: Bethyl A301–041A (western), Santa Cruz sc-32761x (ChIP). Arid1b: Abcam ab57461
(western), Santa Cruz sc-32762x (ChIP). Arid2 Bethyl A302–230A (western/ChIP). Nucleolin
Bethyl (A300–711A). H3K27ac (ChIP) Abcam ab4729.
siRNA and shRNA knockdown experiments
siRNA 2 × 106 HepG2 cells were grown as above and reverse transfected with RNAimax
reagent (Life Technologies) using 30nM siRNA and 10uL RNAimax in 6cm dishes at 6.6 × 105
/mL. After 72 hours of incubation RNA was harvested using Trizol (Life Technologies) and
further purified using a RNAeasy clean up kit (Qiagen). siRNAs used were—Arid1a (siGenome
L-017263-00-0005 (Dharmacon), Silencer Select s15786 (Life Technologies), Arid1b
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(siGenome M-013970-00-0005 (Dharmacon), 1027416 (Qiagen)), Arid2 (Silencer Select
s47042(Life Technologies), siGenome M-026945-01-0005 (Dharmacon), Non-targeting Con-
trol (AM4611, Life Technologies).
shRNA shRNA constructs targeting ARID1A (TRCN0000059091: shRNA-1,
TRCN0000059090: shRNA-2) and a non-silencing construct were used to generate lentivirus
by transfecting HEK293T cells with the pLKO.1 lentiviral constructs, pMD2.G and psPAX2
(psPAX2 and pMD2.6 were a gift from Didier Trono—Addgene plasmid # 12260 and plasmid
# 12259). After 72 hours viral supernatent was harvested concentrated using Lenti-X (Clon-
tech). Knockdowns for ChIP experiments were generated by transducing HepG2 cells on 6 cm
plates and selecting for puromycin resistance starting 48 hours post-transduction. Cells for
ChIP were handled as described below.
Chromatin immunoprecipitation
Prior to starting ChIP, 5–10ug antibody were incubated with 50uL Dynal beads (Life Technolo-
gies), for rabbit antibodies we used a 1:1 mix of protein A and protein G beads, for mouse anti-
bodies protein G only. Antibody/bead mixture was incubated overnight at 4°C in 0.5% Bovine
Serum Albumin (BSA) in PBS. 50–100 × 106 cells were fixed in 0.3% formaldehyde for 30 min-
utes at 4°C and then quenched with 0.125M glycine for 5 minutes at room temperature. Pellets
were washed three times in cold PBS and frozen in liquid nitrogen and stored at -80°C. For each
ChIP 2 × 107 cells were thawed on ice and resuspended in 1mL swelling buffer (25mMHepes,
1.5mMMgCl2, 10mM KCl, 0.1% NP-40) with 1mM PMSF and incubated 10 minutes on ice. Pel-
lets were dounced 20 strokes with B pestle and spun at 2000RPM for 7 minutes at 4°C in a swing-
ing bucket centrifuge. Cell pellets then resuspended in 5mL sucrose buffer A (0.32M Sucrose,
15mMHepes pH 7.9, 50mM KCl, 2mM EDTA, 0.5mM EGTA, 0.5mM PMSF) and layered
gently over 5mL sucrose buffer B (30% Sucrose, 15mMHepes pH 7.9, 50mMKCl, 2mM EDTA,
0.5mM EGTA, 0.5mM PMSF) and centrifuged 10 minutes at 3000 RPM in a swinging buffer
centrifuge at 4°C. Nuclei were washed once in 10mL digestion buffer (15mMHepes ph7.9,
60mMKCl, 15mMNaCl, 0.32M Sucrose, 0.5mM PMSF) and pelleted for 10 minutes at 2000
RPM. They were then resuspended in 1mL per 4 × 107 cells with 3.3uL CaCl2 per mL with 1X
protease inhibitor (Roche) and 1mM PMSF and incubated for 5 minutes at 37°C. 0.5uL MNAse
(NEB, 2 × 106 units/mL) was added to tubes and incubated 15 minutes at 37°C. MNase digestion
was stopped by adding 0.1 volumes 0.5M EDTA and reactions were incubated for 5 minutes on
ice. Nuclei were then passed 5 times through a 20G needle, 1 volume of double concentration
LB3 (20mM Tris-HCl pH 8.0, 100mMNaCl, 1mM EDTA, 0.5mM EGTA, 0.1% Na-Deoxycho-
late, 0.5% N-lauroylsarcosine) was added and lyaste was passed 5X through 25G needle. Triton
X-100 was added to final concentration of 1%, and cells were spun at 13000G in microfuge at 4°
for 15 minutes. Supernatant was saved, and the pellet was resuspended in 1X LB3 buffer with 1%
Triton X-100 and incubated 1–2 hours rotating at 4°. Following another 13000G spin, the super-
natants were combined and 10% was reserved as input DNA. 1mL (equivalent to 20 × 106 cells)
was added to the prepared beads and incubated overnight. Beads were washed 8 times in RIPA
(50mMHepes-KOH, pH 7.6, 500mM LiCl, 1mM EDTA, 1%NP-40, 0.7% Na-deoxycholate) and
1 time in TE (10mMTris-HCl pH 8.0, 1mM EDTA) supplemented with 50mMNaCl before elu-
tion in 100uL 1%SDS, 100mMNaHCO3 for 17 minutes at 65 degrees with agitation. Supernatant
was removed and supplemented with 5uL of 5MNaCl and incubated overnight at 65°C. 3uL
RNAseA(30mg/mL) was added to reactions and incubated for 30 minutes at 37°C, followed by
5ul Proteinase K (20mg/mL) at 56° for 1 hour. Reactions were purified using a Zymo Clean and
Concentrator Chip Kit (D5205) and concentration was measured using qubit (Life Technologies)
before library preparation.
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Co-immunoprecipitation
Small-scale nuclear extracts were prepared as previously described [20]. Immunoprecipitations
were performed by incubating antibodies to ARID1A, ARID1B, ARI2, or IgG overnight at 4°
followed by incubated for 2 hours with M280 Sheep-anti rabbit more mouse beads (Life Tech-
nologies). The beads were washed 4 times with 150mMNacl, twice with 100mMNaCl, and
once with 60mMNaCl before eluting in 1X laemmli loading buffer by boiling for 10 minutes.
RNA-seq library prep
RNA-seq library preparation was done using the dUTP incorporation method modified from
[44]. Briefly, 30ug total RNA was poly A+ selected using Dynal poly A+ beads. RNA was then
fragmented using Ambion Fragmentation Reagent (AM8740, Life Technologies) for 4 minutes
at 70 degrees and cleaned using a Zymo ssDNA/RNA kit (D7010). The fragmented RNA was
used in a first strand synthesis reaction using NEB random primers (S1330S, NEB) and Super-
script III (18080044, Life Technologies) following manufacturers instructions. Reaction was
then purified and used in a second strand synthesis reaction with dUTP replacing dTTP in the
nucleotide mix for 2 hours at 16°C. The reaction was purified with 1.8 volumes Ampure XP
beads (A63880, Beckman-Coulter) and used in standard Illumina Library Preparation (See sec-
tion below), except prior to final amplification libraries were treated with Uracil DNA-Glycosy-
lase (M0280S, NEB) to degrade the d-UTP marked second strand.
Library prep
We prepared libraries using above cDNA or ChIP DNA for Illumina sequencing using stan-
dard protocols and NEB Next Reagents. Briefly, DNA ends were repaired using end repair
module (E6050S, NEB). Then molecules were A-Tailed using Klenow exo− and Illumina
Adapters were ligated to molecules using the Quick Ligation Module (E6056S). Libraries were
then purified twice with Ampure XP beads (1 volume first round, 0.8 volumes second round.
Libraries were then amplified using NEBNExt Q5 polymerase and quantitated and submitted
for Illumina Sequencing at the University of North Carolina at Chapel Hill High Throughput
Sequencing Facility.
Data analysis
Data were processed using R 3.0 [45] and Python 2.7.6 (http://python.org) and packages indi-
cated below. Code used in analysis is available at http://github.com/jraab/raab_swisnf_2015.
ChIP-seq analysis
Single end 50bp reads from two independent experiments were aligned to hg19 using bowtie2
(2.2.1) (http://bowtie-bio.sourceforge.net/bowtie2/index.shtml [46] filtered for duplicates and
merged using samtools (0.1.19) [47] prior to final peak calling. Peaks were called using MACS2
(https://github.com/taoliu/MACS/ [48]) using –broad -q 0.01 settings. Peaks were further pro-
cessed by using pybedtools [49, 50] to merge all peaks within 100 basepairs of each other and
removing any peaks that are found in the ENCODE blacklist regions. Each peak was assigned
to the nearest gene and the relationship to genomic features was assigned using Gencode V16
for gene annotations.
RNA-seq analysis
Single-end 50bp reads were aligned to hg19 using Tophat2 (2.0.13) [51] and htseq-count using
-s reverse -m intersection-strict -i gene_name (0.5.4p5) [52] was used to process aligned reads
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into gene level counts using Gencode V16 annotations. Differential expression was tested
usinge DESeq2 (1.6.3) [53]. For UCSC Genome Browser Tracks replicates were merged and
converted to strand specific bigwig files.
Chromatin module identification
Data sets for transcription factors and histone modifications were obtained from the ENCODE
portal (http://genome.ucsc.edu/ENCODE/downloads.html) and were downloaded as aligned
reads (BAM format). Replicates were merged and signal centered on each ARID peak was cal-
culated using python scripts (available in github repository). Median signal over each peak was
used to calculate a pairwise correlation (Spearman) for each pair of ChIP-seq peaks. These
were clustered (1-cor) and visualized using the gplots::heatmap.2 function in R. Clusters were
assigned using k-means (k = 9) and the network diagram of similarities between clusters was
derived from the number of shared transcription factors (edges) between any two clusters
(nodes). We removed any clusters with a median enrichment of<0.1.
RT-PCR
RT-PCR was performed by reverse transcribing RNA using Multiscribe (Life Technologies—
4311235), followed by quantitative PCR using Ssofast EvaGreen Supermix (Bio-Rad—172-
5203) reagents per manufacturers instructions on a Bio-Rad CFX-96 machine. Primer
sequences were as follows: Arid1a-F AGATGGGACACCCAAGACAG, Arid1a-R
CTTCCTCTCAGGCTCACCAC; Arid1b-F TCTCCTGTTGGCTCTCCTGT, Arid1b-R
GTGTGCCTGCCATAAAACCT; Arid2-F GGAGCAGATCCAAGCACTGT Arid2-R
GACTGCCACAGACACATGAAG; Epha2-F AGGCTACGAGAAGGTGGAGG, Epha2-R
CAAGCAGGGGCTCTCAGAT; S100A14-F TGGCTCCTCCTGTCTTGTCT S100A14-R
CCCACTGTGTCTGGTCCTTT; Spock2-F TGCCAGAAGGTGAAGTGCAG Spock2-R
TTTCCATGGAGTTTCACGGT; TNS4-F AGCTCTTCATACCGAGGCTC, TNS4-R
CTTTGGCAGACGACTCGATG. AVIL-F AGGCAGAGCACTACCTGTGG; AVIL-R
AGTGTTCTCGCTGCCATCA; AXL-F CCGTAACCTCCACCTGGTC; AXL-R ATCC-
CATCGTTTGACAGCAC; CD109-F TTTCCTCCTAATACAGTGACTGGC; CD109-R
CCATTGATGGAAGGACCAAG; EPHA1-F GGAGAGTGACCAGGATGTGG; EPHA1-R
ACACAAGGTCTCGAATGGTGA; S100A3-F AAATACAAGCTCTGCCAGGC; S100A3-R
GTAGAGACAGAGGCAGGCAA; FOXM1-F AGGAGAATTGTCACCTGGAGC; FOXM1-R
GTAAGAGTAGGGTGGCCGCT; KISS1R-F AACTCGCTGGTCATCTACGT; KISS1R-R
AACTTGCACATGAAGTCGCC; MCM7-F GCGATGGCACTGAAGGACTA; MCM7-R
TTCCCGAGTTCATCATCCTG; TIE1-F GACTGACCCAGCTTTTGCTC; TIE1-R
CTGCAATCTTGGAGGCTAGG; All experiments were normalized to expression of Gusb
(Gusb-F AAACGATTGCAGGGTTTCAC, Gusb-R CTCTCGTCGGTGACTGTTCA), and
presented as the log2 ratio of siArid/siNTG.
Pathway analysis
Gene lists were compared to the MSigDB database (downloaded—2015-05-05). P-values were
generated using the hypergeometric test, using all possible genes in the MSigDB as the back-
ground and were adjusted using the Benjanmi-Hochberg correction for multiple testing.
Ethics statement
All animal work was conducted according to relevant national and international guidelines
and was approved by UNC Chapel Hill’s IACUC
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Accession numbers
Raw and processed data can be found at GEO GSE69568—Analysis scripts can be found at
http://github.com/jraab/raab_swisnf_2015 All sequencing Data are also available as a UCSC
Genome Browser Trackhub using http://genome.ucsc.edu/cgi-bin/hgTracks?db =
hg19&hubUrl = http://trackhubs.its.unc.edu/magnuslb/jraab/swi_snf/hub.txt
Supporting Information
S1 Fig. Relative Expression of ARID subunits in cancer cell lines. ARID1A, ARID1B, and
ARID2 TPM values from ENCODE experiments [18]. The red line indicates the average of the
ENCODE experiments for that cell type.
(EPS)
S2 Fig. Efficiency of ARID knockdown. A. Western blot of protein levels of each ARID fol-
lowing knockdown. B. Expression values (log2 Fold Change) measured by RNA-seq for each
ARID following loss of each ARID.
(EPS)
S3 Fig. Validation of RNA-seq by qPCR. A-C. Validation of RNA-seq data using the primary
set of siRNA used in RNA-seq (siRNA 1) and a second siRNA set (siRNA 2) at selected genes
following knockdown of ARID1A (A), ARID1B (B), and ARID2 (C). Error bars represent stan-
dard error of the mean for 2 independent experiments.
(EPS)
S4 Fig. Overlap of ChIP-seq peaks. A-C. Overlap of ARID1A, ARID1B, or ARID2 with SNF5/
BAF47, demonstrating fraction of ARID peaks associated with core SWI/SNF factor by peak
calls. D. Union of all ARID peaks overlapping SNF5/BAF47 peaks. E. Comparison of SNF5/
BAF47 peak calls in our manuscript with those in Euskirchen et. al. [23].
(EPS)
S5 Fig. Histone modifications associated with ARID bound regions. H3K4me1, H3K4me3,
and H3K27ac signal was measured centered on the ARID bound regions using information
from the ENCODE project [18, 55]. Data are represented as the average signal which light
shading depicting the 95% confidence interval.
(EPS)
S6 Fig. Comparison of signal between different categories of ARID peaks. The signal at
each set of ARID peaks (ARID1A alone—top panels, ARID1B alone—second panels, ARID2
alone—third panels, Multiple peaks—bottom panels), for each of the ARIDs and SNF5/BAF47
(ARID1A—red, ARID1B- blue, ARID2- green, SNF5- purple) +/- 2kb from the midpoint of
the peak to demonstrate the accuracy of the ‘Alone’ vs ‘Multiple’ peak definitions.
(EPS)
S7 Fig. Correlation analysis of transcription factors and histone modifications at ARID
bound regions. The average enrichment for each of 77 ENCODE mapped factors [18] at the
four classes of ARID peaks (ARID1A alone (A), ARID1B alone (B), ARID2 alone (C), and mul-
tiple bound (D); green track on left is enrichment). For each of these factors we compared the
enrichment at each set of arid peaks using Spearman Correlation coefficients and clustered
these data to yield the middle heatmaps showing which sets of signals were most related. We
used k-means clustering (k = 9) to define interesting clusters. Red is highly correlated, Blue is
anti correlated. Important clusters from main Fig 4A are labelled.
(EPS)
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S8 Fig. Genomic location of factors found in Arid1b-specific cluster.We calculated the sig-
nal enrichment for each of the members of the ARID1B-specific cluster (MYBL2, MBD4,
TEAD4, and NFIC) at three types of genomic features (exons were excluded because too few sites
existed, which led to very high noise in that data). The top row consists of ARID1B-multiple
ARID sites, and the bottom row is ARID1B-single ARID sites. The colors distinguish the 3 geno-
mic locations of these peaks. Solid line represents average signal intensity with the shaded region
denoting the 95% confidence interval centered at the midpoint of the ARID1B peak +/- 2.5kb.
(EPS)
S9 Fig. Validation of ARID1A dependence on gene expression changes following ARID2
loss. A. Western blot of combinatorial knockdown using siRNA set #1 from Fig 5B. B. qPCR
validation of single and combinatorial knockdown of ARID1A and ARID2 using siRNA set #2.
C. qPCR validation of gene expression changes and ARID1A dependence for gene activation at
competitively regulated genes following combinatorial knockdown of ARID1A and ARID2
using siRNA set #2. Error bars represent standard error of the mean, n = 2.
(EPS)
S10 Fig. Pairwise gene expression changes of directly bound ARID targets. A. Pairwise gene
expression changes of ARID1A and ARID1B directly bound co-regulated genes. B. ARID1A
ChIP-seq enrichment at all genes significantly regulated by ARID1A and ARID1B C. ARID1B
ChIP-seq enrichment at all genes significantly regulated by ARID1A and ARID1B D. Pairwise
gene expression changes of ARID1A and ARID2 directly bound co-regulated genes. E.
ARID1A ChIP-seq enrichment at all genes significantly regulated by ARID1A and ARID2. F.
ARID2 ChIP-seq enrichment at all genes significantly regulated by ARID1A and ARID2 G.
Pairwise gene expression changes of ARID1B and ARID2 directly bound co-regulated genes.
H. ARID1B ChIP-seq signal at all genes significantly regulated by ARID1B and ARID2. I.
ARID2 ChIP-seq signal at all genes significantly regulated by ARID1B and ARID2.
(EPS)
S11 Fig. Genomic location of peaks associated with ARID1B and ARID2 activation or
repression. Percent of ARID1B or ARID2 peaks that are involved in activation or repression
that localize to different classes of genomic features. The shift towards distal/intronic peaks in
the repressed category is statistically significant for ARID1B peaks(Chi Squared p-
value = 0.02), but not for ARID2 peaks (p-value = 0.08). N = 72, 233, 80, 314 for ARID1B acti-
vated, ARID1B repressed, ARID2 activated, ARID2 repressed, respectively.
(EPS)
S12 Fig. Enrichment of transcription factors and histone modifications at peaks associated
with cooperation or competition. These data underly the selection of genes in Fig 7B. We
compared the mean signal values for different histone modifications and transcription factors
at ARID1A or ARID2 peaks associated with genes we classified as competitively or coopera-
tively regulated. We used these data to identify transcription factors or histone modifications
specifically associated with a particular mode of regulation.
(EPS)
S13 Fig. Enrichment of transcription factors and histone modifications at peaks associated
with activation or repression. These data underly the selection of genes in Fig 7C. We com-
pared the mean signal values for histone modifications and transcription factors at ARID1B
and ARID2 peaks associated with either activation or repression. These data were used to iden-
tify factors that were more enriched when associated with repressed compared to active regions
or vice versa.
(EPS)
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S1 Table. Additional file 1—ARID1A bound regions. Bed file of ARID1A bound regions
(hg19).
(BED)
S2 Table. Additional file 2—ARID1B bound regions. Bed file of ARID1B bound regions
(hg19).
(BED)
S3 Table. Additional file 3—ARID2 bound regions. Bed file of ARID2 bound regions (hg19).
(BED)
S4 Table. Additional file 4—SNF5 bound regions. Bed file of SNF5 bound regions (hg19).
(BED)
S5 Table. Additional file 5—ENCODE data sets used.
(CSV)
S6 Table. Additional file 6—All expressed genes with associated ARID transcription
changes and peak information. CSV file of all expressed genes and the transcriptional changes
associated with each ARID at that gene and whether an ARID peak is assigned to that gene.
(CSV)
S7 Table. Additional file 7—Pathway analysis of ARID1A regulated genes. Excel file with
pathway analysis of alone and jointly regulated ARID1A genes.
(XLSX)
S8 Table. Additional file 8—Pathway analysis of ARID1B regulated genes. Excel file with
pathway analysis of alone and jointly regulated ARID1B genes
(XLSX)
S9 Table. Additional file 9—Pathway analysis of ARID2 regulated genes. Excel file with
pathway analysis of alone and jointly regulated ARID2 genes.
(XLSX)
S10 Table. Additional file 10—All ARIDs differentially expressed genes. CSV file containing
all significantly changed genes following ARID knockdown. Contains ‘Alone’ or ‘Jointly’ regu-
lated label.
(CSV)
S1 Text. Supplementary figures and text. Single PDF of additional figures and text.
(PDF)
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